Quest Diagnostics Reports Third Quarter 2022 Financial Results; Raises Guidance for Full Year 2022

Go back to Quest Diagnostics Reports Third Quarter 2022 Financial Results; Raises Guidance for Full Year 2022

Quest Diagnostics (DGX) Tops Q3 EPS by 19c; Guides Higher

October 20, 2022 6:47 AM EDT

Quest Diagnostics (NYSE: DGX) reported Q3 EPS of $2.36, $0.19 better than the analyst estimate of $2.17. Revenue for the quarter came in at $2.49 billion versus the consensus estimate of $2.33 billion.

GUIDANCE:

Quest Diagnostics sees FY2022 EPS of $9.75-$9.95, versus the consensus of... More